Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TOT Biopharm Company has inaugurated a new 50,000m² factory complex in eastern China's Suzhou Industrial Park, Suzhou.
Subscribe to our email newsletter
The new complex, which is part of $100m complex, is a specialized branch for research, development, production and marketing of anti-cancer drugs globally.
The complex includes an oral anti-cancer drug plant with separate production facilities for both cytotoxics and non-cytotoxics, an injected anti-cancer drug plant and a GMP bio pilot plant with a capacity of 500L cell culture/ purification/ filling.
TOT Biopharm’s new factory complex is also expected to develop the bio-pharmaceutical sector set forth in China’s 12th Five-Year Development Planning for Strategic Emerging Industries.
The company’s core products include Liposomal technology-based specialty drugs, biologics and innovative drugs.
TOT Biopharm is also planning to commence the second-stage construction to expand its production scale for cancer treatments.